Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostatin in NSCLC with Leptomeningeal Metastasis
NCT04356118Phase 4Unknown
- Start
- Jun 2020
- Primary completion
- Jun 2023
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 4 trial of endostar in leptomeningeal metastasis (LM). Status: unknown.
02
Drugs
endostar
03
Conditions
leptomeningeal metastasis (LM)
Beyond the preview
Go deeper on NCT04356118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04356118.